News Daily News EuroCTO CASTLE: Prediction Model for CTO PCI Success Shows Good Discriminating Ability L.A. McKeown February 04, 2019
News Features Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis? Michael O'Riordan February 01, 2019
News Daily News AHA Warns of Stagnating CVD Gains, Barriers to Access, and Dismal Drug Pipeline Michael O'Riordan January 29, 2019
News Daily News Dose-Response Benefits for Fiber Intake Seen Across Wide Swath of Acquired Diseases Shelley Wood January 15, 2019
News Daily News Cancer Patients Should Not Be Automatically Ruled Out for TAVR: Analysis L.A. McKeown January 10, 2019
News Daily News Tailoring Antiplatelet Therapy to Bleeding Risk Post-PCI Improves Outcomes and Cuts Costs, Model Suggests L.A. McKeown January 08, 2019
News Daily News Working Less, Earning Less: Stroke, MI, and Cardiac Arrest Have Long-term Labor Consequences Michael O'Riordan January 07, 2019
News Daily News Operators’ Radiation Exposure in the Cath Lab Directly Tied to Patient BMI Todd Neale January 04, 2019
News Daily News AHA Scientific Statement: Get PAD Patients Moving to Improve Symptoms and QoL L.A. McKeown January 03, 2019
News Daily News Data Hint at Unintended Consequences of Hospital Readmissions Reduction Program L.A. McKeown December 21, 2018
News Daily News Listen Up! Bacteria Commonly Found on Physician Stethoscopes Michael O'Riordan December 14, 2018
News Conference News WCC 2018 Rising CVD Threatens Middle East and North Africa Todd Neale December 13, 2018
News Daily News Now You See It: Imaging Helps Lower CVD Risk Burden in Primary Prevention Michael O'Riordan December 10, 2018
News Conference News WCC 2018 E-Cigarettes: Plausible Heart Risks Flagged in New Review Todd Neale December 10, 2018
News Daily News Quality of Anticoagulation Therapy Lower in Black Patients With A-fib Todd Neale December 03, 2018
News Daily News Frailty Linked to Higher Bleeding Risk Among Acute MI Patients Undergoing PCI L.A. McKeown November 19, 2018
News Conference News AHA 2018 Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study Michael O'Riordan November 15, 2018
News Conference News VIVA 2018 Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease L.A. McKeown November 15, 2018
News Conference News AHA 2018 Sit Less, Move More: New Physical Activity Guidelines Stress Movement at All Ages Michael O'Riordan November 12, 2018
News Conference News AHA 2018 Post-MI Yoga: Randomized Trial Shows Feasibility and Safety as an Option for Cardiac Rehab Yael L. Maxwell November 10, 2018